Who is moneynews

Health and Money News does not disclose ownership and there does not appear to be a source of revenue. In review, Health and Money News is a blog that publishes far-right conspiracies and pseudoscience.

During the Covid pandemic of , they have routinely promoted false information such as mask use being related to cancer That Mask Is Giving You Lung Cancer? This story is not properly sourced to credible scientific information and is actually false. In short, according to the website, all the measures necessary to combat Covid are dangerous and deadly, but the actual disease, which to date has killed more than K Americans, is a harmless hoax or conspiracy theory.

In general, Health and Money News is a source that has zero credibility and is very dangerous if taken seriously, as virtually every bit of information we reviewed was either false or purposely misleading. Overall, we rate Health and Money News an extreme right biased, tin foil hat conspiracy and quackery level pseudoscience website, based on nearly all information being either false or misleading.

This site is not credible on any level and promotes dangerous disinformation. Please enable JavaScript in your browser to complete this form. Message Vote. Left vs. Right Bias: How we rate the bias of media sources.

Phase 1 Of Vaccination Campaign: Furthermore, the companies behind the vaccines have the public good, rather than profits, at the forefront of their considerations, so that investors need to distinguish between the companies that have developed the vaccines and those who are part of the vaccine production supply chain.

The developers — such as Pfizer, Moderna, and AstraZeneca — have largely viewed this first phase of the vaccine drive as an act of public service. Low Prices At Least For Now: AstraZeneca is the most obvious example as it is explicitly producing its vaccine on a not-for-profit basis.

On the other hand, the companies involved in the vaccine production process are participating on a much more commercial level. They will therefore see a greater financial benefit from this current "emergency" phase of the vaccine roll-out. The Time Of Greater Rewards Will Come: However, the next phase may bring more substantial profits, since the current cohort of available vaccines is unlikely to be the last, given the number of COVID variants emerging meanwhile.

Ultimately, suggests Schroders ' expert, COVID vaccines are likely to become part of the existing winter season vaccination programme. That will then provide more enduring, long-term value to these companies.

And the companies in the supply chain will continue to benefit too, along with the developers. This article originally appeared on Financialounge. It does not represent the opinion of Benzinga and has not been edited. Benzinga does not provide investment advice. All rights reserved. Stars stunned by 'mismanaged set' in fatal prop-gun shooting.

Civil rights pioneer seeks expungement of '55 arrest record.